Skip to main content

Table 1 Characteristics of the included study population according to LST withholding or withdrawing during ICU stay

From: Limitation of life-sustaining therapies in critically ill patients with COVID-19: a descriptive epidemiological investigation from the COVID-ICU study

Variable

Missing

All

(n = 4671)

No limitation

(n = 3996)

LST withholding

(n = 378)

LST withdrawing

(n = 297)

Age (years), median (IQR)

63 (54, 70)

61 (53, 69)

70 (63, 76)

71 (63, 78)

Female, n (%)

33

1191 (26)

1009 (25)

108 (29)

74 (25)

Healthcare worker, n (%)

83

160 (3)

149 (4)

7 (2)

4 (1)

Nursing home resident, n (%)

47

74 (2)

46 (1)

16 (4)

12 (4)

Obesity (BMI > 30 kg/m2), n (%)

336

1681 (39)

1457 (39)

134 (39)

90 (33)

SAPS II score, median (IQR)

403

37 (28, 50)

35 (27, 48)

44 (36, 56)

47 (35, 59)

SOFA score, median (IQR)

679

5 (3, 8)

4 (3, 8)

7 (4, 10)

7 (4, 10)

Hypertension, n (%)

 

2221 (48)

1831 (46)

224 (59)

166 (56)

Diabetes, n (%)

 

1271 (27)

1034 (26)

134 (35)

103 (35)

Coronary artery disease, n (%)

 

509 (11)

381 (10)

71 (19)

57 (19)

Chronic heart failure, n (%)

 

172 (4)

111 (3)

32 (8)

29 (10)

Chronic respiratory disease, n (%)

40

993 (21)

804 (20)

106 (28)

83 (28)

Immunodeficiency, n (%)

38

337 (7)

263 (7)

38 (10)

36 (12)

Chronic renal failure, n (%)

38

    

 Yes

 

324 (7)

247 (6)

45 (12)

32 (11)

 Chronic dialysis

 

112 (2)

88 (2)

15 (4)

9 (3)

Hematological malignancy, n (%)

 

129 (3)

93 (2)

17 (4)

19 (6)

Clinical frailty scale score

465

2 (2–3)

2 (2–3)

3 (2–4)

3 (2–4)

Date of ICU admission, n (%)

167

    

 Before March 15, 2020

 

n = 295

225 (76)

39 (13)

31 (11)

 From March 16 to 31, 2020

 

n = 2752

2343 (85)

227 (8)

182 (7)

 From April 1 to 15, 2020

 

n = 1214

1072 (88)

75 (6)

67 (6)

 After April 16, 2020

 

n = 243

208 (86)

22 (9)

13 (5)

Time between first symptoms and ICU admission

404

    

 < 4 days

 

n = 421

327 (78)

50 (12)

44 (10)

 4–7 days

 

n = 1379

1138 (83)

134 (10)

107 (8)

 ≥ 8 days

 

n = 2467

2200 (89)

151 (6)

116 (5)

During the first 24 h, n (%)

 Standard oxygen therapy

94

1367 (29)

1202 (30)

103 (27)

62 (21)

 Noninvasive ventilation

148

271 (6)

217 (5)

30 (8)

24 (8)

 High-flow oxygen

162

873 (19)

767 (19)

67 (18)

39 (13)

 Invasive mechanical ventilation

76

2866 (61)

2377 (60)

260 (69)

229 (77)

ARDS severity*, n (%)

412

    

 Mild

 

580 (24)

488 (24)

43 (19)

49 (24)

 Moderate

 

1197 (49)

1000 (49)

109 (47)

88 (44)

 Severe

 

677 (28)

534 (26)

80 (34)

63 (32)

Static compliance, mL/cmH2O

341

35 (29–43)

35 (29–43)

33.6 (28–42)

33.3 (28–42)

  1. LST life-sustaining treatment, IQR interquartile range, SAPS II simplified acute physiology score II, BMI body mass index, ICU intensive care unit, SOFA sequential organ failure assessment, ARDS acute respiratory distress syndrome
  2. *Data reported for patients under invasive mechanical ventilation